oltipraz has been researched along with arachidonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SG; Shin, SM | 1 |
| Cho, IJ; Kim, SG; Kwon, YN; Shin, SM | 1 |
2 other study(ies) available for oltipraz and arachidonic acid
| Article | Year |
|---|---|
Inhibition of arachidonic acid and iron-induced mitochondrial dysfunction and apoptosis by oltipraz and novel 1,2-dithiole-3-thione congeners.
Topics: Apoptosis; Arachidonic Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Formazans; Humans; In Situ Nick-End Labeling; Iron; Liver Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Pyrazines; Reactive Oxygen Species; Tetrazolium Salts; Thiones; Thiophenes; Time Factors | 2009 |
Oxidized metabolites of oltipraz exert cytoprotective effects against arachidonic acid through AMP-activated protein kinase-dependent cellular antioxidant effect and mitochondrial protection.
Topics: AMP-Activated Protein Kinases; Antioxidants; Apoptosis; Arachidonic Acid; Cytoprotection; Drug Antagonism; Membrane Potential, Mitochondrial; Mitochondria; Pyrazines; Reactive Oxygen Species; Thiones; Thiophenes; Tumor Cells, Cultured | 2009 |